Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01217918 · ClinicalTrials.gov registry record · Phase 1
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01217918 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 30 participants.
The verdict
NCT01217918, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.
Interventions
- DRUG 1 mg
- DRUG 5 mg
- DRUG 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01217918
The ClinicalTrials.gov registry entry for NCT01217918 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 1 mg is the first listed.
NCT01217918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01217918 about?
NCT01217918 is a clinical study titled "Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects". Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.
What is the current status of trial NCT01217918?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-10. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01217918?
The interventions under investigation include: 1 mg (DRUG), 5 mg (DRUG), 10 mg (DRUG).
Who is sponsoring clinical trial NCT01217918?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.